Literature DB >> 9724847

Immune cell signaling aberrations in human lupus.

S N Liossis1, P P Sfikakis, G C Tsokos.   

Abstract

A large array of heterogeneous aberrations of the immune system have been described in systemic lupus erythematosus (SLE). Since the function and the fate of the immune system cells are governed principally by the biochemical events that follow ligation of specialized cell-surface receptors, we will review in this article recent developments in our understanding of abnormalities in the biochemistry of signals generated either by the antigen-receptor complex or by systems of costimulatory cell-surface molecules, like the CD28/CTLA4:CD80/CD86 and the CD40:CD40L pairs found on the surface membrane of lupus immune cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724847     DOI: 10.1007/BF02786511

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  68 in total

1.  Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.

Authors:  B Kovacs; S N Liossis; G J Dennis; G C Tsokos
Journal:  Autoimmunity       Date:  1997       Impact factor: 2.815

2.  Hyperresponsive B cells in CD22-deficient mice.

Authors:  T L O'Keefe; G T Williams; S L Davies; M S Neuberger
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

3.  Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.

Authors:  C H June; M C Fletcher; J A Ledbetter; L E Samelson
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

4.  Defective CD2 pathway T cell activation in systemic lupus erythematosus.

Authors:  D A Fox; J A Millard; J Treisman; W Zeldes; A Bergman; J Depper; R Dunne; W J McCune
Journal:  Arthritis Rheum       Date:  1991-05

5.  Polygenic control of susceptibility to murine systemic lupus erythematosus.

Authors:  L Morel; U H Rudofsky; J A Longmate; J Schiffenbauer; E K Wakeland
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

6.  Kinetics and extent of T cell activation as measured with the calcium signal.

Authors:  C Wülfing; J D Rabinowitz; C Beeson; M D Sjaastad; H M McConnell; M M Davis
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

7.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

8.  Defective antigen-presenting cell function in patients with systemic lupus erythematosus.

Authors:  G C Tsokos; B Kovacs; P P Sfikakis; S Theocharis; S Vogelgesang; C S Via
Journal:  Arthritis Rheum       Date:  1996-04

9.  Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.

Authors:  J G Wilson; W D Ratnoff; P H Schur; D T Fearon
Journal:  Arthritis Rheum       Date:  1986-06

10.  Treatment of murine lupus with CTLA4Ig.

Authors:  B K Finck; P S Linsley; D Wofsy
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

View more
  3 in total

Review 1.  Targeting CD40L: a promising therapeutic approach.

Authors:  Dimitris Daoussis; Andrew P Andonopoulos; Stamatis-Nick C Liossis
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.

Authors:  Martina Ahlmann; Georg Varga; Karsten Sturm; Ralph Lippe; Konrad Benedyk; Dorothee Viemann; Thomas Scholzen; Jan Ehrchen; Frank U Müller; Matthias Seidl; Marek Matus; George C Tsokos; Johannes Roth; Klaus Tenbrock
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

3.  Prolactin alters the mechanisms of B cell tolerance induction.

Authors:  Subhrajit Saha; Juana Gonzalez; Gabriel Rosenfeld; Harold Keiser; Elena Peeva
Journal:  Arthritis Rheum       Date:  2009-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.